Distinguished in Hepatitis B

Joo H. Sohn

Guri-si, KR 
Distinguished in Hepatitis B
Guri-si, KR 
OverviewLocationsClinical Research

Overview

Joo Sohn practices in Guri-si, Republic of Korea. Sohn is rated as a Distinguished expert by MediFind in the treatment of Hepatitis B. Their top areas of expertise are Portal Hypertension, Cirrhosis, Hepatitis B, Ascites, and Endoscopy.

Their clinical research consists of co-authoring 90 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 22 articles and participated in 1 clinical trial in the study of Hepatitis B.

Locations

Guri-si, Republic of Korea
Other Locations
Seoul, Republic of Korea
Gyeonggi-do, Republic of Korea
Daegu, Republic of Korea
Jeong Ill Suh, Jeong Bae Park, Gyeongju, 780350, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Perioperative Care of Hepatic Venous Pressure Gradient (HVPG) Measurement (CHESS1904): An International Multicenter Survey
Perioperative Care of Hepatic Venous Pressure Gradient (HVPG) Measurement (CHESS1904): An International Multicenter Survey
Enrollment Status: Completed
Publish Date: April 25, 2023
Intervention Type: Other
A Phase Ⅲ, Multi-center, Randomized, Double-blinded, Parallel Study to Assess the Antiviral Activity and Safety of Besifovir 150 mg Compared to Tenofovir 300 mg in Chronic Hepatitis B Patients for 48 Weeks
A Phase Ⅲ, Multi-center, Randomized, Double-blinded, Parallel Study to Assess the Antiviral Activity and Safety of Besifovir 150 mg Compared to Tenofovir 300 mg in Chronic Hepatitis B Patients for 48 Weeks
Enrollment Status: Unknown
Publish Date: January 27, 2020
Intervention Type: Drug
Study Drugs: Besifovir, Tenofovir
Study Phase: Phase 3
View 1 Less Clinical Trial

90 Total Publications

Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study.
Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study.
Journal: Annals of medicine
Published: January 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Sohn's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 12 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile